| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $32,029,863 ) (Continued on the next page) |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23NS116033 | Dynamic Risk Prediction of Life-Threatening Mass Effect After Ischemic Stroke | 001 | 4 | NIH | 5/14/2024 | $33,250 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23NS116033 | Dynamic Risk Prediction of Life-Threatening Mass Effect After Ischemic Stroke | 000 | 4 | NIH | 3/29/2024 | $184,244 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K24AT011561 | Mentoring and Patient-Oriented Research in Mind and Body Practices | 000 | 4 | NIH | 8/16/2024 | $121,371 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DA054363 | Retention and Re-Engagement in Treatment for Addiction following Serious Injection Related Infections (RETAIN) | 000 | 4 | NIH | 5/22/2024 | $189,432 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA054268 | MOUD Comparative Effectiveness Study | 000 | 4 | NIH | 5/1/2024 | $542,395 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HS028814 | Implementing Telemedicine to Improve Appropriate Antibiotic Prescribing for Acute Respiratory Tract Infections | 000 | 3 | AHRQ | 5/9/2024 | $487,417 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R13DA052198 | Substance Use Modeling Consortium Workshop to Support the Public Health Response to the Overdose Crisis in North America | 001 | 4 | NIH | 7/8/2024 | $24,956 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AI152930 | Understanding HIV's impact on RR/MDR-TB development and transmission through genomics | 000 | 4 | NIH | 6/10/2024 | $186,325 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA055488 | Persistent HIV-1 expression and microglia dysfunction | 000 | 4 | NIH | 5/17/2024 | $739,881 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23HL145126 | Improving Prehospital Pediatric Emergency Readiness with Telemedicine | 002 | 5 | NIH | 8/1/2024 | $0 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23HL145126 | Improving Prehospital Pediatric Emergency Readiness with Telemedicine | 001 | 5 | NIH | 7/23/2024 | $166,321 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H79SM084960 | Boston Services for Trauma And Resources for families (Boston STAR) | 003 | 4 | SAMHSA | 6/12/2024 | $380,797 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DA054328 | Improving value-based healthcare delivery for opioid use disorder | 000 | 4 | NIH | 6/19/2024 | $175,889 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DE029862 | Validation of Light Scattering Spectroscopy for Intra-operative Margin Guidance during Oral Cancer Resection | 000 | 5 | NIH | 7/1/2024 | $703,116 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK119542 | The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 Nephropathy | 000 | 5 | NIH | 3/18/2024 | $185,132 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DA052821 | Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV) | 000 | 3 | NIH | 7/11/2024 | $175,694 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AI186597 | The relationship between HIV exposure, contact networks, and TB in children under 5 years old | 000 | 1 | NIH | 8/20/2024 | $193,316 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DK128858 | The Boston University Kidney and Medical Engineering Program (BU-KIDMEP) | 002 | 4 | NIH | 5/16/2024 | $4,970 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DK128858 | The Boston University Kidney and Medical Engineering Program (BU-KIDMEP) | 001 | 4 | NIH | 5/14/2024 | $7,456 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DK128858 | The Boston University Kidney and Medical Engineering Program (BU-KIDMEP) | 000 | 4 | NIH | 2/21/2024 | $111,830 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T2537593 | Addiction Medicine Fellowship | 00 | 5 | HRSA | 5/24/2024 | $786,697 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T2537593 | Addiction Medicine Fellowship | 01 | 5 | HRSA | 7/23/2024 | $24,612 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | UT953486 | Supporting Fetal Alcohol Spectrum Disorders (FASD) Screening and Intervention | 00 | 1 | HRSA | 9/18/2024 | $949,979 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | UT953486 | Supporting Fetal Alcohol Spectrum Disorders (FASD) Screening and Intervention | 01 | 1 | HRSA | 9/23/2024 | $0 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK141016 | Role of Intravenous ultrasound (IVUS) in arteriovenous hemodialysis access dysfunction | 000 | 1 | NIH | 9/10/2024 | $809,595 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R61DA059856 | Substance Use Prevention for Recently displaced Adults (SUPRA) | 001 | 1 | NIH | 4/3/2024 | $0 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R61DA059856 | Substance Use Prevention for Recently displaced Adults (SUPRA) | 000 | 1 | NIH | 3/28/2024 | $779,967 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK138309 | Effectiveness Trial to Support Adoption of Hybrid Closed Loop Therapy in Underserved Adults with Type 1 Diabetes: Impact of System Functionality and Features on Lived Experience | 001 | 1 | NIH | 4/1/2024 | $0 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK138309 | Effectiveness Trial to Support Adoption of Hybrid Closed Loop Therapy in Underserved Adults with Type 1 Diabetes: Impact of System Functionality and Features on Lived Experience | 000 | 1 | NIH | 12/29/2023 | $899,996 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AI187175 | Defective HIV proviruses and Persistent Innate Immune Activation | 000 | 1 | NIH | 8/22/2024 | $765,274 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | U01DK133092 | Boston Chronic Kidney Disease Research Biopsy Center | 000 | 3 | NIH | 8/19/2024 | $799,999 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R34MH137223 | Developing measures to improve access to integrated mental health care services in under-resourced global settings | 000 | 1 | NIH | 9/3/2024 | $271,157 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R03DK140290 | ApolipoproteinL1 Genotypes and Biomarkers of Immune Activation and Tubular Injury | 000 | 1 | NIH | 8/26/2024 | $133,500 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL168098 | Identification of a mechanosensor in juxtaglomerular cells for the regulation of renin synthesis and secretion | 000 | 1 | NIH | 1/8/2024 | $675,003 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HD115574 | Efficacy of Teleconsultation to Improve Prehospital Patient Safety for Critically Ill Infants and Children - A Multicenter, Simulation-based Randomized Control Trial | 000 | 1 | NIH | 7/30/2024 | $812,343 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R61DA062217 | A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk | 000 | 1 | NIH | 9/23/2024 | $1,233,787 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R21DA062256 | The Youth Empowerment Study (YES) | 000 | 1 | NIH | 9/20/2024 | $497,002 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R03HL171172 | Developing an assessment toolkit and training for teleconsultation as an intervention to improve prehospital patient safety in children | 001 | 1 | NIH | 2/14/2024 | -$147,946 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R03HL171172 | Developing an assessment toolkit and training for teleconsultation as an intervention to improve prehospital patient safety in children | 001 | 1 | NIH | 2/14/2024 | $147,946 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R03HL171172 | Developing an assessment toolkit and training for teleconsultation as an intervention to improve prehospital patient safety in children | 000 | 1 | NIH | 1/22/2024 | $147,946 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T32MH135857 | Boston University Medical Campus- Massachusetts General Hospital Global Psychiatric Clinical Research Training Program | 000 | 1 | NIH | 6/17/2024 | $412,778 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H9E53185 | Transition for Youth with Autism and/or Epilepsy Demonstration Projects | 00 | 1 | HRSA | 7/5/2024 | $449,795 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DK136973 | Deep learning approach for the assessment of arterial and arteriolar lesions in kidney biopsies and prediction of cardiovascular risk | 000 | 1 | NIH | 8/19/2024 | $152,453 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL166606 | Targeting Energetics to Improve Outcomes in Hypertrophic Cardiomyopathy | 000 | 1 | NIH | 4/1/2024 | $833,881 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | P30HS029752 | Boston Health Equity & community-Aligned Learning Health System (Boston-HEALHS) | 001 | 1 | AHRQ | 1/3/2024 | $0 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | P30HS029752 | Boston Health Equity & community-Aligned Learning Health System (Boston-HEALHS) | 000 | 1 | AHRQ | 12/27/2023 | $984,408 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01AI167733 | Nutritional Interventions to End Tuberculosis among persons with HIV in India (NUTRIENT-India) | 000 | 2 | NIH | 8/7/2024 | $127,514 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MD019068 | Adapting an Evidence-Based Intervention to Improve the Hospital Discharge Process for Patients with Limited English Proficiency | 001 | 2 | NIH | 7/8/2024 | $161,950 |
| | 2024 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R34DA058124 | Sustaining recovery for people on opioid agonist treatment with conversational agents | 001 | 2 | NIH | 8/9/2024 | $221,624 |
|
